| Name | Title | Contact Details |
|---|
St Rose Hospital is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. St Rose Hospital is based in Hayward, CA. You can find more information on St Rose Hospital at www.strosehospital.org
ControlRad is a privately-held medical technology company developing innovative products that dramatically reduce the lifetime risk of radiation exposure from fluoroscopically guided interventional procedures (FGIP) for patients and healthcare professionals.
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
careMESH is a first-of-its-kind healthcare communications platform bringing together a national provider directory, admit/discharge notifications, secure communications, and transition of care workflows into a single service. careMESH connects the care continuum by allowing any provider working with any electronic health record to communicate and collaborate with any other, instantly. careMESH`s cloud-based services efficiently allow hospitals and health systems, health information exchanges, public health agencies, and physician groups to communicate about patients, maintain complete control over when and where information is shared, and rapidly reduce reliance on outdated tools such as fax and phone calls.
DNA2.0 is a privately-held, leading synthetic genomics company, headquartered in Menlo Park, CA.